Trinity, Florida (June 28, 2016) — Lawrence Hochman, DO, MHSA (Masters in Health Services Administration), FACRO (Fellow of the American College of Radiation Oncology), was recently awarded a Masters degree in Health Services Administration from Lake Erie College of Osteopathic Medicine.
Lake Erie College of Osteopath Medicine’s MHSA curriculum offers an 18 month Masters Degree program with a maximum of 50 credits. There are 10 core courses (for 30 credits) which are required to be taken by all students. The students also take three electives in areas of health institution administration and public health services. Dr. Hochman also had to submit a request for validation for his healthcare administration experience and complete a Master’s thesis project or a capstone experience. Dr. Hochman graduated with a 4.0 GPA.
Dr. Hochman was recently awarded certification in the new SpaceOAR program. Dr. Hochman is helping to pioneer a new tool aimed to protect prostate cancer patients from the negative effects of radiation therapy. Dr. Hochman was one of the first in Florida to inject a patient at FCA with SpaceOAR® hydrogel, the first FDA cleared spacing device to protect the rectum in men undergoing radiation therapy for prostate cancer. At this writing 30 patients have benefited from this procedure at FCA.
About Florida Cancer Affiliates
Florida Cancer Affiliates (FCA) is a community-based radiation oncology, medical oncology, and hematology practice with convenient locations throughout Florida, from Naples and Ft. Myers to Trinity, Hudson, Brooksville, The Villages, Ocala and Panama City. The integrated clinical team of FCA employs the latest technologies and drug therapies to ensure patients receive advanced care close to home. The comprehensive treatment centers include outpatient treatment and diagnostic facilities providing chemotherapy, hematology services, radiation therapy including stereotactic, brachytherapy and PET/CT imaging, clinical research, pharmacy and laboratory, as well as financial counseling and patient support services.
The practice is committed to providing patients with the best and most advanced care available. They offer therapies proven to be effective, along with advanced diagnostic and treatment technologies. They also provide access to new investigational drugs through clinical trials. By participating in clinical trials that test new drugs or various combinations of treatments, patients have the opportunity to receive new therapies not yet available outside these clinical trials. To learn more about Florida Cancer Affiliates, go to www.floridacancer.com.
Florida Cancer Affiliates is united in healing with The US Oncology Network, one of the nation’s largest networks of integrated community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. As an affiliate of The US Oncology Network, FCA is united with nearly 1,000 physicians nationwide. Florida Cancer Affiliates participates in clinical trials through US Oncology Research, which has played a role in 50 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.